These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2141221)

  • 1. Iodine-123 phenylpentadecanoic acid myocardial scintigraphy in patients with left ventricular hypertrophy: alterations in left ventricular distribution and utilization.
    Wolfe CL; Kennedy PL; Kulkarni PV; Jansen DE; Gabliani GI; Corbett JR
    Am Heart J; 1990 Jun; 119(6):1338-47. PubMed ID: 2141221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iodine-123 phenylpentadecanoic acid and single photon emission computed tomography in identifying left ventricular regional metabolic abnormalities in patients with coronary heart disease: comparison with thallium-201 myocardial tomography.
    Hansen CL; Corbett JR; Pippin JJ; Jansen DE; Kulkarni PV; Ugolini V; Henderson E; Akers M; Buja LM; Parkey RW
    J Am Coll Cardiol; 1988 Jul; 12(1):78-87. PubMed ID: 3259960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iodine 123-phenylpentadecanoic acid myocardial scintigraphy: usefulness in the identification of myocardial ischemia.
    Kennedy PL; Corbett JR; Kulkarni PV; Wolfe CL; Jansen DE; Hansen CL; Buja LM; Parkey RW; Willerson JT
    Circulation; 1986 Nov; 74(5):1007-15. PubMed ID: 3769161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myocardial scintigraphy with iodine 123-labeled fatty acids].
    Dudczak R
    Wien Klin Wochenschr Suppl; 1983; 143():3-35. PubMed ID: 6228070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial scintigraphy with iodine-123 phenylpentadecanoic acid and thallium-201 in patients with coronary artery disease: a comparative dual-isotope study.
    Zimmermann R; Rauch B; Kapp M; Bubeck B; Neumann FJ; Seitz F; Stokstad P; Mall G; Tillmanns H; Kübler W
    Eur J Nucl Med; 1992; 19(11):946-54. PubMed ID: 1425781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of gallopamil on iodine-123-phenyl-pentadecanoic acid and thallium 201 uptake in patients with coronary heart disease].
    Tillmanns H; Zimmermann R; Kapp M; Rauch B; Neumann FJ; Schlumpp K; Bubeck B; Georgi P; Kübler W
    Z Kardiol; 1989; 78 Suppl 5():77-82. PubMed ID: 2698567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of myocardial viability using 123I-labeled iodophenylpentadecanoic acid at sustained low flow or after acute infarction and reperfusion.
    Yang JY; Ruiz M; Calnon DA; Watson DD; Beller GA; Glover DK
    J Nucl Med; 1999 May; 40(5):821-8. PubMed ID: 10319757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal myocardial fatty acid metabolism in dilated cardiomyopathy detected by iodine-123 phenylpentadecanoic acid and tomographic imaging.
    Ugolini V; Hansen CL; Kulkarni PV; Jansen DE; Akers MS; Corbett JR
    Am J Cardiol; 1988 Nov; 62(13):923-8. PubMed ID: 3263035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reduced myocardial fatty acid utilization in coronary heart disease following symptom limited ergometric stress. Detection of pathologic metabolic patterns using iodine-123-phenylpentadecanoic acid and sequential SPECT].
    Reske SN; Nitsch J; von der Lohe E; Simon HJ; Bardos P; Büll U
    Z Kardiol; 1989 Apr; 78(4):262-70. PubMed ID: 2786661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhomogeneous exercise uptake and accelerated washout of a radioiodinated fatty acid analogue in syndrome X. A SPECT study of the left ventricle.
    Walamies M; Koskinen M; Uusitalo A; Niemelä K
    Int J Card Imaging; 1994 Jun; 10(2):123-9. PubMed ID: 7963750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of myocardial ischemia by gallopamil: a dual-isotope study with thallium-201 and iodine-123 phenylpentadecanoic acid.
    Zimmermann R; Tillmanns H; Kapp M; Grethe U; Neumann FJ; Schlumpp K; Rauch B; Bubeck B; Kübler W
    J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S40-7. PubMed ID: 1284156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of improvement in left ventricular function with iodine-123-IPPA after coronary revascularization.
    Hansen CL; Heo J; Oliner C; Van Decker W; Iskandrian AS
    J Nucl Med; 1995 Nov; 36(11):1987-93. PubMed ID: 7472586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of myocardial viability by dynamic tomographic iodine 123 iodophenylpentadecanoic acid imaging: comparison with rest-redistribution thallium 201 imaging.
    Iskandrian AS; Powers J; Cave V; Wasserleben V; Cassell D; Heo J
    J Nucl Cardiol; 1995; 2(2 Pt 1):101-9. PubMed ID: 9420774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [123I]-phenylpentadecanoic acid uptake in patients with dilated cardiomyopathy.
    Miche E; Radzewitz A; Notohamiprodjo G; Baller D; Kloppe A; Eckert S; Gleichmann U
    Eur J Heart Fail; 2002 Aug; 4(4):431-8. PubMed ID: 12167380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viability after myocardial infarction: can it be assessed within five minutes by low-dose dynamic iodine-123-iodophenylpentadecanoic acid imaging with a multicrystal gamma camera?
    Murray GL; Schad N; Bush AJ
    Angiology; 1997 Apr; 48(4):309-19. PubMed ID: 9112879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-nuclide study of the myocardium using 201Tl and 123I-labeled fatty acids in non-ischemic myocardial diseases.
    Knapp WH; Vyska K; Machulla HJ; Notohamiprodjo G; Schmidt U; Knust EJ; Gleichmann U
    Nuklearmedizin; 1988 Jun; 27(3):72-8. PubMed ID: 3405780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of 123I-phenylpentadecanoic acid (IPPA) metabolic and thallium 201 perfusion imaging in stable coronary artery disease.
    Walamies M; Turjanmaa V; Koskinen M; Uusitalo A
    Eur Heart J; 1993 Aug; 14(8):1079-87. PubMed ID: 8404938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iodophenylpentadecanoic acid-myocardial blood flow relationship during maximal exercise with coronary occlusion.
    Caldwell JH; Martin GV; Link JM; Krohn KA; Bassingthwaighte JB
    J Nucl Med; 1990 Jan; 31(1):99-105. PubMed ID: 2295946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise testing in patients with electrocardiographic evidence of left ventricular hypertrophy.
    Alshami AA; Jolly SR; Smith FL; Reeves WC; Movahed A
    Clin Nucl Med; 1994 Oct; 19(10):904-9. PubMed ID: 7805329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial perfusion imaging with thallium-201 to assess left ventricular hypertrophy and regional ischaemia in hypertensive patients.
    Folmer SC; Wieling W; Dunning AJ
    Eur J Clin Invest; 1981 Aug; 11(4):291-7. PubMed ID: 6457747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.